MARROW TRANSPLANTATION FOR THALASSEMIA AFTER TREATMENT WITH BUSULFAN AND CYCLOPHOSPHAMIDE
MARROW TRANSPLANTATION FOR THALASSEMIA AFTER TREATMENT WITH BUSULFAN AND CYCLOPHOSPHAMIDE
复制标题
DOI：
10.1111/j.1749-6632.1985.tb17212.x
复制
发表时间：
1985-01-01
影响因子：
5.2
通讯作者：
SPARAVENTI, G
中科院分区：
文献类型：
--
作者：
LUCARELLI, G;POLCHI, P;SPARAVENTI, G
材料和方法所有患者都有记录的/3纯合子地中海贫血。8岁以下的患者接受了定期输血和螯合治疗，没有骨骼畸形，也没有器官损伤，被归类为“良好风险”。全
MATERIALS AND METHODSAll patients had documented/3-homozygous thalassemia. Patients under eight years of age who had received regular transfusions and chelating treatment without skeleton deformities and without organ damage were classified as “good risk.” All